The Scotts Miracle-Gro Company (SMG) Key Metrics
SMG valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $3.18B
- Enterprise value
- $5.15B
- P/E (TTM)
- 19.5 10-yr median 22.5
- Forward P/E
- 12.9
- PEG ratio
- 0.74
- Price / sales
- 0.9 10-yr median 1.7
- Price / book
- 21.9 10-yr median 8.9
- EV / EBITDA
- 11.9 10-yr median 14.2
- Dividend yield
- 4.84% $2.64 a year
- Beta
- 1.85
SMG key metrics, FY2016–FY2025
Fiscal year ended September 30, 2025 · U.S. dollarsSMG valuation Price multiples at each fiscal year-end price.
SMG returns How much profit the business earns on the capital it uses.
SMG per-share figures Results divided by the shares outstanding at year-end.
SMG financial health Debt, liquidity and how easily interest is covered.
SMG efficiency & capital use Working capital cycle and where the cash goes.
SMG valuation history
SMG returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
SMG debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
SMG cash returned to shareholders
SMG price vs earnings per share
SMG key metrics
FY2016–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $3.34B | $4.92B | $2.89B | $2.37B | $8.37B | $8.70B | $5.73B | $4.50B | $5.86B | $5.16B |
| Enterprise value | $5.69B | $7.37B | $5.77B | $5.56B | $10.72B | $10.37B | $7.37B | $6.48B | $7.14B | $6.43B |
| P/E ratio | 23.0 | — | — | — | 16.3 | 22.5 | 12.4 | 70.6 | 26.8 | 16.1 |
| Price / sales | 1.0 | 1.4 | 0.8 | 0.6 | 1.7 | 2.1 | 1.8 | 1.7 | 2.2 | 1.8 |
| Price / book | — | — | — | 16.1 | 8.3 | 12.5 | 7.9 | 12.5 | 8.9 | 7.1 |
| Price / free cash flow | 12.2 | 8.4 | 6.6 | — | 50.9 | 17.6 | 31.1 | 16.4 | 20.6 | 28.8 |
| Price / operating cash flow | 9.0 | 7.4 | 5.5 | — | 30.8 | 15.6 | 25.3 | 13.1 | 16.6 | 21.7 |
| EV / sales | 1.7 | 2.1 | 1.6 | 1.4 | 2.2 | 2.5 | 2.3 | 2.4 | 2.7 | 2.3 |
| EV / EBITDA | 13.4 | 34.2 | — | — | 12.6 | 15.1 | 9.5 | 22.6 | 15.2 | 12.5 |
| EV / free cash flow | 20.8 | 12.6 | 13.2 | — | 65.1 | 20.9 | 39.9 | 23.6 | 25.1 | 35.9 |
| Earnings yield | 4.3% | −0.7% | −13.1% | −18.4% | 6.1% | 4.5% | 8.0% | 1.4% | 3.7% | 6.2% |
| Free cash flow yield | 8.2% | 11.8% | 15.1% | −10.2% | 2.0% | 5.7% | 3.2% | 6.1% | 4.9% | 3.5% |
| Dividend yield | 4.6% | 3.1% | 5.2% | 7.0% | 1.7% | 4.7% | 2.2% | 2.7% | 2.1% | 2.3% |
| Shareholder yield (dividends + buybacks) | 5.2% | 3.2% | 5.5% | 17.9% | 3.3% | 5.3% | 2.2% | 10.0% | 6.4% | 4.9% |
| Share price at fiscal year-end | $56.95 | $86.70 | $51.68 | $42.75 | $146.36 | $152.91 | $101.82 | $78.73 | $97.34 | $83.27 |
| Per share | ||||||||||
| Revenue per share | $58.14 | $62.55 | $63.42 | $70.70 | $86.10 | $72.61 | $56.06 | $46.64 | $43.89 | $45.74 |
| Earnings per share | $2.47 | −$0.61 | −$6.79 | −$7.88 | $8.96 | $6.81 | $8.18 | $1.12 | $3.63 | $5.17 |
| Operating cash flow per share | $6.33 | $11.75 | $9.48 | −$2.32 | $4.75 | $9.81 | $4.03 | $6.00 | $5.88 | $3.83 |
| Free cash flow per share | $4.67 | $10.27 | $7.83 | −$4.37 | $2.88 | $8.70 | $3.28 | $4.80 | $4.72 | $2.89 |
| Cash per share | $0.62 | $1.26 | $0.57 | $1.56 | $4.27 | $0.29 | $0.33 | $0.59 | $2.00 | $0.81 |
| Book value per share | −$6.09 | −$6.88 | −$4.77 | $2.66 | $17.72 | $12.25 | $12.85 | $6.30 | $10.99 | $11.78 |
| Tangible book value per share | −$17.09 | −$18.54 | −$16.93 | −$12.37 | −$5.27 | −$9.25 | −$9.29 | −$18.23 | −$8.78 | −$6.35 |
| Dividends per share | $2.63 | $2.66 | $2.66 | $2.99 | $2.50 | $7.23 | $2.21 | $2.10 | $2.00 | $1.88 |
| Capex per share | $1.66 | $1.48 | $1.66 | $2.05 | $1.87 | $1.10 | $0.75 | $1.19 | $1.16 | $0.94 |
| Debt per share | $40.55 | $44.33 | $51.90 | $58.92 | $45.37 | $29.57 | $29.34 | $35.31 | $23.27 | $21.23 |
| Shares outstanding | 58.7M | 56.8M | 56.0M | 55.5M | 57.2M | 56.9M | 56.3M | 57.1M | 60.2M | 62.0M |
| Change in shares outstanding | +3.3% | +1.4% | +0.9% | −3.0% | +0.5% | +1.1% | −1.4% | −5.1% | −2.9% | −0.3% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | — | — | −75.4% | 59.9% | 54.5% | 85.1% | 12.5% | 31.4% | 47.0% |
| Return on invested capital (ROIC) | 11.6% | 7.1% | −4.6% | −10.2% | 19.3% | 18.8% | 22.1% | 9.3% | 13.9% | 15.9% |
| Return on assets (ROA) | 5.2% | −1.1% | −9.9% | −9.6% | 12.5% | 12.1% | 15.1% | 2.2% | 7.9% | 12.0% |
| Return on tangible assets | 6.9% | −1.6% | −13.9% | −12.6% | 14.7% | 18.0% | 25.8% | 3.9% | 14.0% | 19.0% |
| Free cash flow margin | 8.0% | 16.4% | 12.3% | −6.2% | 3.3% | 12.0% | 5.8% | 10.3% | 10.8% | 6.3% |
| Income quality (OCF / net income) | 2.56 | — | — | — | 0.53 | 1.44 | 0.49 | 5.38 | 1.62 | 0.74 |
| Financial health | ||||||||||
| Total debt | $2.38B | $2.52B | $2.91B | $3.27B | $2.60B | $1.68B | $1.65B | $2.02B | $1.40B | $1.32B |
| Cash & short-term investments | $36.6M | $71.6M | $31.9M | $86.8M | $244.1M | $16.6M | $18.8M | $33.9M | $120.5M | $50.1M |
| Net debt | $2.34B | $2.45B | $2.87B | $3.18B | $2.35B | $1.67B | $1.63B | $1.98B | $1.28B | $1.27B |
| Debt / equity | — | — | — | 22.14 | 2.56 | 2.41 | 2.28 | 5.61 | 2.12 | 1.80 |
| Debt / assets | 0.87 | 0.88 | 0.85 | 0.76 | 0.54 | 0.50 | 0.55 | 0.66 | 0.51 | 0.47 |
| Net debt / EBITDA | 5.51 | 11.34 | — | — | 2.77 | 2.43 | 2.11 | 6.92 | 2.73 | 2.46 |
| Current ratio | 1.27 | 1.31 | 1.81 | 2.06 | 1.77 | 1.28 | 1.68 | 1.45 | 1.62 | 1.66 |
| Quick ratio | 0.47 | 0.52 | 0.67 | 0.66 | 0.79 | 0.63 | 0.81 | 0.66 | 0.87 | 0.90 |
| Interest coverage | 2.8 | 1.3 | -1.0 | -3.7 | 9.2 | 6.6 | 6.8 | 2.3 | 5.8 | 7.9 |
| Working capital | $200.6M | $230.1M | $624.1M | $1.02B | $883.6M | $266.2M | $421.2M | $273.0M | $337.2M | $391.6M |
| Invested capital | $1.99B | $2.06B | $2.61B | $3.33B | $3.36B | $2.36B | $2.36B | $2.34B | $1.94B | $2.00B |
| Tangible asset value | −$1.00B | −$1.05B | −$947.9M | −$686.5M | −$301.5M | −$520.4M | −$523.0M | −$1.04B | −$528.8M | −$393.9M |
| Net current asset value | −$2.16B | −$2.28B | −$2.28B | −$2.17B | −$1.76B | −$1.46B | −$1.26B | −$1.81B | −$1.20B | −$1.10B |
| Graham number | — | — | — | — | $59.76 | $43.32 | $48.63 | $12.57 | $29.95 | $37.00 |
| Graham net-net per share | −$44.74 | −$48.67 | −$53.23 | −$57.05 | −$45.75 | −$35.04 | −$31.71 | −$38.31 | −$25.68 | −$25.47 |
| Capital allocation | ||||||||||
| Dividends paid | $154.3M | $151.3M | $149.1M | $166.2M | $143.0M | $411.2M | $124.5M | $120.0M | $120.3M | $116.6M |
| Share buybacks (net) | $18.4M | $5.1M | $9.3M | $257.9M | $129.3M | $53.2M | $3.1M | $327.7M | $255.2M | $137.4M |
| Dividend payout ratio | 106.3% | — | — | — | 27.9% | 106.1% | 27.0% | 188.4% | 55.1% | 36.4% |
| Dividends + buybacks / free cash flow | 63.1% | 26.8% | 36.1% | — | 165.4% | 93.8% | 69.2% | 163.2% | 132.0% | 141.8% |
| Capex / revenue | 2.9% | 2.4% | 2.6% | 2.9% | 2.2% | 1.5% | 1.3% | 2.6% | 2.6% | 2.1% |
| Capex / operating cash flow | 26.2% | 12.6% | 17.5% | — | 39.4% | 11.2% | 18.7% | 19.9% | 19.7% | 24.6% |
| Capex / depreciation | 1.30 | 1.04 | 1.00 | 1.08 | 1.14 | 0.66 | 0.47 | 0.82 | 0.87 | 0.79 |
| Stock-based compensation / revenue | 2.0% | 2.3% | 1.9% | 0.9% | 0.8% | 1.4% | 1.2% | 1.5% | 1.0% | 0.6% |
| R&D / revenue | 1.0% | 1.0% | 1.0% | 1.2% | 0.9% | 1.0% | 1.3% | 1.6% | 1.5% | 1.6% |
| SG&A / revenue | 16.3% | 14.4% | 13.9% | 13.7% | 13.6% | 16.6% | 16.8% | 17.6% | 18.5% | 16.5% |
| Efficiency | ||||||||||
| Days sales outstanding | 19.4 | 24.7 | 31.0 | 36.4 | 35.5 | 34.6 | 35.8 | 40.9 | 40.6 | 30.3 |
| Days of inventory on hand | 90.9 | 99.1 | 140.2 | 147.7 | 92.3 | 76.2 | 87.3 | 90.2 | 93.5 | 84.9 |
| Days payables outstanding | 37.3 | 35.5 | 43.8 | 61.7 | 52.8 | 39.7 | 31.2 | 30.8 | 31.1 | 32.2 |
| Cash conversion cycle (days) | 73.1 | 88.3 | 127.5 | 122.4 | 75.0 | 71.1 | 91.9 | 100.3 | 103.1 | 83.0 |
| Receivables turnover | 18.77 | 14.77 | 11.77 | 10.03 | 10.28 | 10.55 | 10.20 | 8.92 | 8.98 | 12.06 |
| Payables turnover | 9.79 | 10.28 | 8.34 | 5.91 | 6.91 | 9.20 | 11.72 | 11.85 | 11.74 | 11.35 |
| Inventory turnover | 4.01 | 3.68 | 2.60 | 2.47 | 3.95 | 4.79 | 4.18 | 4.05 | 3.90 | 4.30 |
| Asset turnover | 1.22 | 1.13 | 0.92 | 0.86 | 1.20 | 1.29 | 1.04 | 0.92 | 0.95 | 1.06 |
| Average receivables | $181.8M | $240.5M | $301.6M | $391.2M | $479.1M | $391.6M | $309.4M | $298.6M | $294.1M | $235.2M |
| Average payables | $241.9M | $262.9M | $346.9M | $516.0M | $500.2M | $302.6M | $182.3M | $151.8M | $142.2M | $162.2M |
| Average inventory | $590.1M | $733.9M | $1.11B | $1.24B | $874.2M | $581.1M | $510.9M | $444.4M | $427.9M | $427.9M |
| Intangibles / total assets | 23.5% | 23.1% | 19.9% | 19.4% | 27.4% | 36.2% | 41.1% | 45.8% | 43.3% | 40.0% |
Computed from SMG's annual financial statements (latest annual report filed November 25, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
SMG valuation and financial ratios
At the end of fiscal 2025 (September 30, 2025), Scotts Miracle-Gro traded at 23.0 times earnings, against a 10-year median of 22.5. Based on the latest twelve months, the trailing P/E is 19.5 and the forward P/E is 12.9. Scotts Miracle-Gro earned a return on invested capital of 11.6% in fiscal 2025. It ended the year with $2.4 billion of debt and $36.6 million in cash and short-term investments, net debt of $2.3 billion. It returned $172.7 million to shareholders: $154.3 million in dividends and $18.4 million in share buybacks, 63% of free cash flow. The share count fell 5.3% from 62.0M to 58.7M over 9 years.
See the SMG income statement, the SMG chart for price history, or the SMG stock overview for the latest quote and news.
SMG key metrics FAQ
What is Scotts Miracle-Gro's P/E ratio?
Scotts Miracle-Gro's trailing P/E ratio is 19.5 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 12.9. At the end of fiscal 2025 it was 23.0, compared with a 10-year median of 22.5.
What is Scotts Miracle-Gro's EV/EBITDA?
Scotts Miracle-Gro's enterprise value was 13.4 times EBITDA at the end of fiscal 2025 (enterprise value $5.7 billion, EBITDA $425.5 million); the current EV/EBITDA is 11.9.
What is Scotts Miracle-Gro's ROIC?
Scotts Miracle-Gro's return on invested capital was 11.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Scotts Miracle-Gro have?
Scotts Miracle-Gro had total debt of $2.4 billion at the end of fiscal 2025 and $2.3 billion of net debt (5.51 times EBITDA).
What is Scotts Miracle-Gro's dividend yield?
Scotts Miracle-Gro's forward dividend yield is 4.84%. Scotts Miracle-Gro paid $154.3 million in dividends in fiscal 2025 ($2.63 per share), a payout ratio of 106.3%.
Does Scotts Miracle-Gro buy back its shares?
Yes. Scotts Miracle-Gro spent $18.4 million on net share repurchases in fiscal 2025 Shares outstanding changed +3.3% over the year, to 58.7M..
What is Scotts Miracle-Gro's free cash flow yield?
Scotts Miracle-Gro generated $273.9 million of free cash flow in fiscal 2025, a free cash flow yield of 8.2% on its market value at year-end ($3.3 billion).
What is Scotts Miracle-Gro's current ratio?
Scotts Miracle-Gro's current ratio was 1.27 at the end of fiscal 2025: current assets were 1.27 times current liabilities.